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Abstract
Age-related macular degeneration (AMD) is a major cause of loss of central vision in the elderly. The formation of drusen, an
extracellular, amorphous deposit of material on Bruch’s membrane in the macula of the retina, occurs early in the course of
the disease. Although some of the molecular components of drusen are known, there is no understanding of the cell
biology that leads to the formation of drusen. We have previously demonstrated increased mitochondrial DNA (mtDNA)
damage and decreased DNA repair enzyme capabilities in the rodent RPE/choroid with age. In this study, we found that
drusen in AMD donor eyes contain markers for autophagy and exosomes. Furthermore, these markers are also found in the
region of Bruch’s membrane in old mice. By in vitro modeling increased mtDNA damage induced by rotenone, an inhibitor
of mitochondrial complex I, in the RPE, we found that the phagocytic activity was not altered but that there were: 1)
increased autophagic markers, 2) decreased lysosomal activity, 3) increased exocytotic activity and 4) release of
chemoattractants. Exosomes released by the stressed RPE are coated with complement and can bind complement factor H,
mutations of which are associated with AMD. We speculate that increased autophagy and the release of intracellular
proteins via exosomes by the aged RPE may contribute to the formation of drusen. Molecular and cellular changes in the old
RPE may underlie susceptibility to genetic mutations that are found in AMD patients and may be associated with the
pathogenesis of AMD in the elderly.
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Introduction
Age-related macular degeneration (AMD) is a progressive
degeneration of the macula of the retina, usually bilateral,
leading to a severe decrease in fine vision and a central scotoma
in the elderly [1]. AMD is broadly classified as either dry (non-
neovascular) or wet (neovascular) [2]. The dry form of AMD,
which is characterized by drusen in the macula, is more common
and accounts for about 85 to 90% of patients with AMD.
Patients with dry AMD have a substantial risk of developing wet
AMD.
Drusen, which may occur throughout the retina, contain
extracellular deposits of biological material adhering to Bruch’s
membrane between the retinal pigment epithelium (RPE) and the
choriocapillaris. The proteins found in drusen are an admixture of
blood proteins, extracellular proteins and intracellular proteins [3].
Although there has been much attention to the blood proteins (eg
complement and CFH) in drusen, there have been few studies on
the intracellular proteins and how they may participate in the
formation of drusen. Notably, the intracellular proteins in drusen
are at least partially intact in that they can be identified by
immunohistochemistry and proteomics. We have investigated the
conditions and pathways by which intracellular proteins in the
RPE become extracellular and, perhaps, end up in drusen.
Our laboratory has previously demonstrated increased mtDNA
damage and decreased DNA repair enzyme capabilities in the
RPE/choroid with age [4]. Defective mitochondria are associated
with aging and may underlie or increase the susceptibility to a
variety of neurodegenerative diseases [5]. Proteomic studies
indicate changes in mitochondria of the RPE at progressive stages
of AMD [6]. Defective mitochondria and other organelles are
cleared from the cell by a process known as autophagy in which
fusion of damaged material with lysosomes and digestion is the
disposal pathway [7]. These processes should keep post-mitotic
cells healthy and functional [8]. Nevertheless, increased mtDNA
damage in the aging RPE may be associated with increased
autophagy.
The RPE, which is adjacent to the photoreceptors and rests on
Bruch’s membrane, phagocytoses and digests the distal parts of the
outer segments of the photoreceptors each day [9,10]. As a
consequence of the daily task of digesting photoreceptor outer
segments (POS) throughout life, the lysosomal apparatus of the
post-mitotic RPE cells must process and eliminate significant loads
of material. In the RPE of old eyes, the physiological lysosomal
load may be further increased by autophagy to remove damaged
mitochondrial material. With age, there may be insufficient
digestion of damaged macromolecules and organelles by the RPE,
which will lead to progressive accumulation of biological
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undigested materials. Thus, we hypothesize that the increased
mtDNA damage associated with normal aging leads to altered
functional capacities of the RPE. Furthermore, age-related
changes in cellular functions of the RPE may lead to release of
intracellular proteins that contribute to the formation of drusen.
These changes with age may provide the background for a genetic
mutation to cause the pathophysiological and immunological
events leading to the development of drusen in dry AMD. Here,
we provide the first evidence for increased autophagy and
increased exocytotic activity in the aged RPE and the presence
of autophagy and exosome markers in drusen of AMD patients.
Methods
Donors
Two independent groups of AMD cases and age-matched
controls were used for this study. Twelve eyes from six donors with
no history of AMD were obtained from the National Disease
Research Interchange. Four eyes from two donors with histories of
AMD were obtained from the National Disease Research
Interchange. Every pair of eye used had the signed consent of
the patient, according to the tenets of the Declaration of Helsinki.
In addition, eight eyes from eight donors with well-documented
AMD were retrieved from the Mark O.M. Tso Ophthalmic
Pathology Laboratory at the Wilmer Eye Institute, Johns Hopkins
University School of Medicine. The use of these human tissues in
our laboratory is exempt from IRB approval.
Mouse eye tissues
Frozen eyes of male C57BL/6 mice from young (4 mos) and old
(24,28 mos) animals were obtained from the tissue bank of the
National Institute on Aging. All experimental protocols were in
compliance with the National Institutes of Health guidelines and
were approved by the Center for Comparative Medicine
Committee at Northwestern University.
Immunohistochemistry
The eyes were fixed in buffered formaldehyde, 4%, were
washed in phosphate-buffered saline (PBS, pH 7.4), embedded in
paraffin and sectioned. The tissue sections were deparaffined with
xylene and a series of graded ethanol steps and rehydrated in PBS.
The tissues were heated at 95uCt o9 9 uC in citrate buffer (pH 6.0)
for 20 min for antigen retrieval. The sections were blocked with
normal goat serum, 5%, for 20 min and incubated at 4uC
overnight with a first primary antibody, a rabbit anti-Atg5 (1:50,
Novus Biologicals), mouse anti-CD63 (1:50, Abcam), goat anti-C3
(1:50, Santa Cruz). Primary antibody was omitted in the negative
control. After several washes, tissue sections were incubated with
the secondary antibody, Alexa Fluor 568 goat anti-rabbit IgG
(1:1000, Molecular Probes) for 1 hr at room temperature. After
washing with PBS, the slides were mounted with Vectorshield
containing DAPI (Vector Laboratory) and observed using confocal
microscopy.
Western blot
Tissues or ARPE-19 cells were lysed in buffer (20 mM HEPES,
pH 7.0, 10 mM KCl, 2 mM MgCl2, 0.5% Nonidet P-40, 1 mM
Na3VO4, 1 mM PMSF, and 0.15 U ml
21 aprotinin) and
homogenized. Protein concentrations were determined using the
Bradford colorimetric assay. Thirty micrograms of each protein
lysate were loaded in each lane in sample buffer (2% SDS, 10%
glycerol, 0.001% bromophenol blue, 1% DTT, and 0.05 M Tris-
HCl, pH 6.8), separated on 10% SDS–PAGE (Invitrogen), and
transferred to a PVDF membrane (Millipore, Temecula, CA). The
blots were blocked with 5% nonfat milk in PBS and incubated
with mouse anti-Atg12 (1:500, GeneTex), rabbit anti-LC3B
(1:1000, Abcam), rabbit anti-Cathepsin D (1:4000, GeneTex),
goat anti-CD63 (1:500, Santa Cruz), mouse anti-LAMP2 (1:500,
Santa Cruz), followed by peroxidase-conjugated donkey anti-goat
IgG (1:15,000; Santa Cruz), goat anti-mouse IgG (1:10,000) or
donkey anti-rabbit IgG (1:15,000) for 1 hr at room temperature.
Finally, the blots were developed by enhanced chemiluminescence
(ECL) (Pierce) on Hyperfilm (Amersham). The immunoblots were
scanned and relative band density was determined using ImageJ
(National Institutes of Health, Bethesda, MD). The densities were
normalized to b-actin and analyzed by a standard two-tailed t-test
using GraphPad Prism.
APRE-19 cell culture
ARPE-19 cells are a transformed human RPE cell line. ARPE-
19 cells were purchased from American Type Culture Collection
(ATCC, Manassas, VA) and maintained in DMEM/F12 with
10% fetal bovine serum (FBS), according to published methods
[11]. ARPE-19 cells were used as indicated below.
In vitro autophagy model: Rotenone induced damage of
mtDNA
To study the autophagy process that occurs in response to
damage of mtDNA, we established an in vitro autophagy model
system using rotenone, a widely used inhibitor of mitochondrial
complex I. Rotenone (Sigma) was used to damage mtDNA.
Reactive oxygen species (ROS) generation by rotenone is
dependent upon the presence of mitochondria [12,13] and
complex I [14]. When rotenone interacts with complex I in
mitochondria, ROS are formed [12,13]. We determined the low
concentrations of rotenone that damaged mtDNA in ARPE-19
cells, without loss of ATP or CoEnzyme Q (CoQ) levels and with
no effect on cell viability, as described below.
Viability assay
The cell viability assay was done based on a published method
[15]. Briefly, ARPE-19 cells were seeded at a density of 8000 cells/
well onto 96-well plates. One day after seeding, the plate were
treated with media containing 0, 0.08, 0.16, 0.31, 0.63, 1.25, 2.5,
5, 10, 20, 40 mM rotenone. After the cells were treated for 24 hr,
the cell viability was quantified by MTT assay (Promega,
Madison, WI), following the manufacturer’s instructions. Briefly,
the wells were washed with normal culture media and incubated
with MTT for an additional 4 hr at 37uC. Absorbance at 570 nm
was determined using a Microplate Reader (Model 680; Bio-Rad,
CA). All assay points were determined in triplicate, and all
experiments were repeated three times.
Quantification of ATP levels in vitro
The ATP levels in the ARPE-19 cells exposed to 0, 0.08, 0.16,
0.31, 0.63, 1.25, 2.5, 5, 10, 20, 40 mM rotenone were measured
with a luciferin-luciferase assay kit (ATPlite, Perkin Elmer Life
Science). A calibration curve for ATP concentrations was obtained
for each experiment by using the same batch of luciferin-luciferase
reagents. Briefly, RPE cells in a 96 well format were treated with a
cell lysing solution which raises the pH of the cell culture media
and inactivates endogenous ATPases. The subsequent addition of
the substrate solution (luciferase-luciferin) lowers the pH to a
suitable level so that the reaction can occur. Plates were sealed and
incubated at room temperature for 10 min and the luminescence
was measured, according to the manufacturer’s instructions.
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The general method for measuring endogenous CoQ levels is
based upon detection by mass spectrometry [16,17]. We adapted
this method for use on ARPE-19 cell pellets. After exposure to
rotenone as above, cell pellets (,5610
26 cells) were re-suspended
in 0.1 ml of water and homogenized (265 sec) with a small
motorized pestle (Kontes) in a 1.7 ml tube. Then, 450 mlo f
isopropanol was added and the mixture homogenized again and
then centrifuged (14000 rpm, 5 min) in a table-top microfuge. The
supernatant was removed to a glass tube to which 20 ng of a
synthetic a tocopherol analog was added as an internal standard.
The resulting pellet was re-extracted with 450 ul of isopropanol
and centrifuged again. Combined supernatants were evaporated to
dryness using a Speed-Vac concentrator. The residue was re-
suspended in 50 ml of 55:45:0.05% isopropanol/methanol/formic
acid (v/v/v) and transferred to a small tube. The mixture was
centrifuged to remove insoluble material and the supernatant
analyzed immediately by liquid chromatography-mass spectrom-
etry (LC-MS) for CoQ content.
CoQ was measured using an Agilent 1100 XCT LC-MS. This
analysis used a reversed phase HPLC column (YMC 2.16100 mm
C18) thermostated at 40uC. The running eluant was 55:45:0.05
isopropanol/methanol/formic acid containing 1 mM methyl-
amine at 150 ml/min. Methylamine was used to increase the
sensitivity of the mass spectrometer for CoQ by producing single
methylammonium ion adducts instead of a mixture of protonated
(MH
+) or sodium (MNa
+) ion species [16]. The electrospray source
of the ion trap mass spectrometer was set in ESI mode with a 20
psi nitrogen nebulizer flow and capillary temperature at 280uC.
The inlet capillary voltage was 22800 V. Helium was used as the
collision gas. The instrument was programmed to scan from 100 to
1200 m/z at 3400 m/z/sec. The m/z range 861–920 was
targeted for MS/MS operations to fragment the target ions of
CoQ. Of the two major forms of CoQ (CoQ9, CoQ10 subscript
refers to the number of isoprene units) found in mammalian
tissues, only the CoQ10 form was detected in RPE cells. Also as
expected, the major peak in the MS/MS spectra of CoQ10 was the
MH
+ ion (m/z 863) due to loss of the methylammonium. CoQ
standards spanning a range of 100 to 2000 pg were used to
calibrate the instrument peak height response for the m/z 894 ion
(M-CH3NH2
+) of CoQ.
Long Extension-Polymerase Chain Reaction (LX-PCR)
LX-PCR [18] was performed on rotenone treated ARPE-19
cells (described above). Genomic DNA was isolated with DNeasy
Blood & Tissue Kit (Qiagen). The quantitation of the purified
genomic DNA, as well as of PCR products, was performed
fluorometrically using the PicoGreen dsDNA reagent (Invitrogen).
LX-PCR was performed with the GeneAmp XL PCR system
(Applied Biosystems), which uses rTth DNA Polymerase XL
enzyme designed to amplify target DNA sequences up to about 40
kB. The amounts of primers were 20 pmol and the Mg
2+
concentration was 1.3 mM. The six pairs of PCR primers
employed in this study are given in Table 1.
All the protocols were initiated by a hot start (75uC, 2 min) prior
to addition of rTth enzyme. For amplification of the long fragment
of mtDNA, the standard thermocycler program included initial
denaturation at 94uC for 1 min, 26 cycles for 15149/14841 or 19
cycles for 15149/5999 of 94uC 15 sec, 65uC 12 min, with final
extension at 72uC for 10 min. To amplify a short mtDNA
fragment (221 bp) the same program as 15149/14841 was used
except that extension temperature was 60uC. To amplify a long
nDNA fragment, the thermocycler profile included initial
denaturation at 94uC for 1 min, 27 cycles for b-globin or 26
cycles for b-polymerase of 94uC 15 sec, 65uC 12 min, with final
extension at 72uC for 10 min. To amplify a short nDNA fragment
(84 bp), the same program as b-globin was used except that
extension temperature was 60uC.
DNA damage was quantified by comparing the relative
efficiency of amplification of large fragments of DNA (16.2 and
7.5 KB from mtDNA and 13.5 and 12.2 KB for nDNA) and
normalizing this to the amplification of smaller (221 bp and 84 bp)
fragments. The template DNA (1,50 ng) was varied so that PCR
products were obtained during the log phase of the PCR
amplification.
Preparation of photoreceptor outer segments (POS)
POS were isolated according to established protocols from
bovine eyes obtained fresh from the slaughterhouse [19]. POS
were stored suspended in 10 mM sodium phosphate, pH 7.2,
0.1 M sodium chloride, 2.5% sucrose at 280uC. Before use, POS
were thawed and labeled by addition of 20% vol of 1 mg/ml
FITC (Molecular Probes) in 0.1 M sodium bicarbonate, pH 9.0,
for 1 hr at room temperature in the dark. POS were then washed
and re-suspended in cell culture media.
Phagocytic activity assay
The phagocytic activity assay was done based on a published
method [20]. Briefly, isolated POS aliquots were stored at 280uC
at a concentration of 10
9 POS/mL. Before use, POS was labeled
with 1 mg/mL fluorescein isothiocyanate (FITC) (Molecular
Probes, Carlsbad, CA) in 0.1 M Na-bicarbonate (pH 9.0), for 1
hr in the dark, before being washed and resuspended in cell
culture medium with 2.5% sucrose. The RPE cells were fed with
FITC-POS (10 POS/RPE cell) for 3 hrs under culture conditions
before rinsing four times with PBS containing 1 mM MgCl2 and
0.2 mM CaCl2. The total fluorescence was recorded at 485/
525 nm using Tecan plate. Each assay was repeated four times.
Intensities were calculated with Graph Pad Prism.
Cathepsin D enzyme activity in vitro
Cathepsin D activity was measured in ARPE-19 cell extracts
using a kit containing a fluorogenic peptide substrate peptide,
Table 1. DNA primers used for LX-PCR
16.2-kb mitochondria fragment
15149 59-TGA GGC CAA ATA TCA TTC TGA GGG GC-39 Sense
14841 59-TTT CAT CAT GCG GAG ATG TTG GAT GG-39 Antisense
7.5 Kb mitochondrial fragment
15149 59-TCT AAG CCT CCT TAT TCG AGC CGA -39 Sense
5999 59-TCT AAG CCT CCT TAT TCG AGC CGA-39 Antisense
Short fragment of mtDNA (221 bp)
14620 59-CCC CAC AAA CCC CAT TAC TAA ACC CA-39 Sense
14841 59-TTT CAT CAT GCG GAG ATG TTG GAT GG-39 Antisense
13.5-kb fragment from the 59 flaking region near the b-globin gene
48510 59-CGA GTA AGA GAC CAT TGT GGC AG-39 Sense
62007 59-GCA CTG GCT TAG GAG TTG GAC T-39 Antisense
12.2 Kb region of the DNA polymerase gene b
2372 59- CAT GTC ACC ACT GGA CTC TGA AC -39 Sense
3927 59- CCT GGA GTA GGA ACA AAA TTG CT -39 Anti-sense
doi:10.1371/journal.pone.0004160.t001
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NH2 (Sigma CS0800), reaction buffer (pH 4.0), and standards.
Reactions were initiated by the addition of substrate and kinetics of
substrate hydrolysis was measured using a fluorescent plate reader
(Biotek Synergy2 Ex 340 nm, Em 460 nm) at 37uC for 15 min with
data points collected every 120 sec. Data was imported to Graph
Pad Prism for analysis and determination of initial rates, and
normalization to total protein assayed.
Cathepsin D enzyme activity in vivo
The targeted peptide substrate (R9-CatD) was developed by
Fischer and coworkers [21]. Peptide R9-CatD contains an N-
terminal nona-arginine tract (R9) that allows uptake by cells and
localization in the lysosomes. The remainder of the substrate,
Lys(Rhod)-Ala-Pro-Ile-Ser-Phe-Phe-Glu-Leu-Lys(Fluor), has two
fluorophores. A fluoroscein (Fluor) is at the C-terminus and a
tetramethylrhodamine (Rhod) is at the N-terminus of the cathepsin
D cleavage sequence. Because of the overlap of the emission and
the excitation spectrum of the dyes, the intact peptide has
quenched fluoroscein emission. Fluoroscein fluorescence increases
with substrate cleavage because of the dissociation of the C-
terminal fluoroscein fluorophore peptide from the remainder of
the substrate. The fluorescence ratio Fluor/Rhod allows the
degree of cleavage to be determined in a substrate concentration
independent manner. After the desired treatment with agents, cells
were washed with serum and dye free cell culture media (DMEM
F12 with HEPES) containing R9-CatD peptide at 2 mM for 1 hr
in serum free media. The media was removed and cells rapidly
washed twice with PBS. Cells were harvested by adding lysis buffer
(200 mL, Cytobuster) and incubated at room temperature for
30 min. Then fluoroscein (485/525) and rhodamine fluorescence
(580/620) were sequentially recorded using a fluorescence plate
reader.
Exosome isolation
All procedures were done at 4uC. ARPE-19 cell culture media
was sequentially purified by removing the pellet after centrifuga-
tion for 10 min at 3006g, 10 min at 20006g, 30 min at 10,0006g
and 1 hr at 100,0006g. The final supernatant was removed as
completely as possible and the pellet re-suspended in 1 ml PBS.
The re-suspended pellets were pooled from all the tubes
containing materials from the same cells into a single centrifuge
tube. Then PBS was added to fill the tube and the tube was
ultracentrifuged at 100,0006g for 1 hr. The supernatant above the
visible pellet was removed and the exosome preparations were re-
suspended in 100–200 ml of fresh PBS.
Analysis of exosomes by flow cytometry
Exosomes were measured using flow cytometry (FACS) to
quantify the levels of proteins on the outer membrane [22]. Briefly,
exosomes were fixed to beads (4.0 mm latex beads, 4% solids,
Interfacial Dynamics 12–4000) by incubation of 5 mg purified
exosomes, as measured by Bradford assay, with 10 ml latex beads
for 15 min at room temperature in a 1.5 ml microcentrifuge tube.
Then PBS was added to a final volume of 1 ml and the
preparation was incubated on a test tube rotator wheel for 2 hr
at room temperature. 110 ml of 1 M glycine was added (i.e.,
100 mM final), mixed gently and let stand on the bench at room
temperature for 30 min. Beads were re-suspended in 0.5 ml PBS/
0.5% BSA, 10 ml coated beads were incubated with 50 ml primary
antibodies: mouse anti-CFH (1:50, Serotec), mouse anti-CD63
(1:50, Abcam), mouse ant-LAMP2 (1:50, Abcam), mouse anti-
CD81 (1:50, Abcam), mouse anti-C3 (1:50, Abcam). Primary
antibody diluted in PBS/0.5% BSA for 30 min at 4uC and then
washed twice with 150 ml PBS/0.5% BSA. The beads were then
incubated with 50 ml anti-mouse Alexis red (1:50, Molecular
Probes) secondary antibody diluted in PBS/0.5% BSA for 30 min
at 4uC, washed twice in PBS/BSA, and re-suspended in 500 mlo f
PBS/BSA. Antibody-labeled exosome-coated beads were analyzed
on a flow cytometer (DakoCytomation CyAn) with the forward
scatter (FSC) and side scatter (SSC) adjusted to see both single
beads and bead doublets. Comparisons were made between
fluorescence obtained with specific antibody and with irrelevant
isotype controls.
CFH/exosome binding
A series of concentrations of CFH: 0, 0.5, 0.05, 0.005,
0.0005 mg/mL were incubated with exosomes overnight at 4uC,
washed in PBS/BSA, and then incubated with 50 ml mouse anti-
C3 (1:50, Abcam) or mouse anti-CFH (1:50, Serotec) primary
antibody diluted in PBS/0.5% BSA for 30 min at 4uC. The
preparation was washed twice with 150 ml PBS/0.5% BSA,
incubated with 50 ml secondary antibody diluted in PBS/0.5%
BSA for 30 min at 4uC, washed twice in PBS/BSA and re-
suspended in 500 ml of PBS/BSA. The antibody-labeled exosome-
coated beads were analyzed in a DakoCytomation CyAn flow
cytometer.
Release of cytokines
Human cytokine array Panel A (R & D) was used for the
determination of cytokines released from ARPE-19 cells after
mtDNA damage (as described above). Briefly, cells were seeded at
a density of 50,000 cells/well into 24-well plates. One day after
seeding, the plates were treated with media containing 0 or
2.5 mM rotenone. After the cells were treated for 24 hr, the
supernatant was collected and the cytokine profile was determined,
following the manufacturer’s instructions.
MCP-1 and MIF ELISA
The release of selected cytokines from ARPE-19 cells was
quantitatively determined after exposure to rotenone at concen-
trations of 0, 0.3, 0.6, 1.2 or 2.5 mM. Culture medium samples
were collected after 24 hr, centrifuged and the supernatant in each
group was used to measure the levels of MCP-1 and MIF with an
ELISA kit, following the manufacturer’s instructions (R&D
Systems, MN).
Results
Autophagy marker, Atg5, in drusen
We found that Atg5, an autophagy marker, was present in
drusen in the retina of normal old eyes and old eyes with AMD.
The distribution of Atg5 was assessed in the eyes of ten donors
(twelve eyes) with AMD and six donors of similar age (twelve eyes)
without AMD (representative samples are shown in Fig. 1). In
donors with AMD, a cluster of Atg5 immunoreactivity was present
in the large drusen found in the sub-RPE space (Fig. 1 A–C, three
different donors). In age-matched eyes without AMD, Atg5 was
present as small isolated spots in drusen and the sub-RPE space
(D–F, three different donors).
Increased autophagy markers in the aged mouse RPE/
choroid
In mammalian cells, an Atg12-Atg5 conjugate associates with
the membranes of precursor autophagosomes [23]. We examined
the autophagy conjugation system by detecting Atg12-Atg5 using a
specific monoclonal antibody raised against a full-length recom-
Autophagy, Exosomes and Drusen
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of old mice but no immunolabeling in the RPE of young mice
(Fig. 2A and B). By Western blots (Fig 2C–F), we found that
autophagy markers, Atg12-Atg5 and LC3B, were increased in
RPE/choroids in old mice (24–28 mos) compared to young mice
(4 mos).
In vitro autophagy induction in an RPE cell line by
rotenone treatment
Autophagy can be initiated by accumulation of damaged
macromolecules, for example damaged mtDNA, during aging
[24]. To study the autophagy process that occurs in response to
damage of mtDNA, we established an in vitro autophagy model
system using rotenone, a widely used inhibitor of mitochondrial
complex I. Our strategy was to use rotenone at a low
concentration so that the respiratory activity of the mitochondria
was not substantially inhibited but ROS were generated that could
damage mtDNA.
ARPE-19 cells are a transformed human RPE cell line, widely
used for studying the RPE in vitro. We determined the
concentrations of rotenone that would not affect ARPE-19 cell
viability as measured by the MTT assay (Fig. 3A). Although ROS
were produced (data not shown), rotenone at concentrations
0.08 mM,2.5 mM did not significantly affect cell viability. To
confirm the lack of impact of low concentrations of rotenone on
overall mitochondrial activity, ATP levels were measured using the
ATP luminescence assay. Fig. 3A demonstrates that rotenone at
concentrations 0.08 mM,2.5 mM did not significantly affect the
cellular ATP level. Student’s t test and one way ANOVA were
performed to determine if there were significant changes in cell
viability and ATP levels with and without rotenone treatment. To
further confirm that low concentrations (0.6–2.5 mM) of rotenone
did not inhibit mitochondrial respiratory activity, we determined
that these concentrations of rotenone did not affect the product of
mitochondrial complex I, CoQ. As shown in Fig. 3B,
0.6 mM,2.5 mM rotenone did not affect the level of CoQ.
Quantification of damaged mtDNA and nDNA in cultured
RPE
Having established that rotenone at low concentrations
(0.08 mM,2.5 mM) had a minor effect on viability, ATP and
CoQ, we then determined whether this treatment damages the
mtDNA and/or nuclear (nDNA). Genomic DNA from six
independent preparations in each group was isolated with DNeasy
Blood & Tissue Kit (Qiagen). Using LX PCR, there was a
significant decrease of the relative amplification of mtDNA, but
not nDNA (Fig. 3C), indicating damaged mtDNA in the
concentration range of 0.6 mM–2.5 mM rotenone, compared with
no rotenone treatment (p,0.05, n=6). Thus, low concentrations
of rotenone used in vitro in an RPE cell line caused, at least in
part, a characteristic of the aging cell, damaged mtDNA. Agarose
gel electrophoresis showed that all mtDNA PCR products were
single bands of the appropriate size (Figure S1). Data are presented
as mean6(SEM) with statistical differences between groups
analyzed by standard two-tailed t-test using GraphPad Prism
software. A p value of less than 0.05 was considered statistically
significant.
Increased autophagy markers associated with mtDNA
damage
We measured autophagy markers, Atg5 and LC3B, using
Western blot in ARPE-19 cells that had damaged mtDNA caused
by rotenone treatment. As shown in Fig. 3D, Atg12-Atg5
conjugates and LC3B were increased ARPE-19 cells with mtDNA.
Figure 1. Immunolocalization of autophagy marker, Atg5, in the human RPE/choroid. In these confocal immunofluorescence images: an-
anti-Atg5 antibody labels particles in drusen (arrows). (A) AMD eye from 94-year-old male; (B) AMD eye from 97-year-old male; (C) AMD eye from 74-
year-old male; (D) non-AMD eye from 75-year-old male ; (E) non-AMD eye from 60-year-old male; (F) non-AMD eye from 87-year-old male. Dr, drusen.
Scale bar=20 mm. Blue: DAPI; red: Atg-5; Green: autofluorescence.
doi:10.1371/journal.pone.0004160.g001
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S2. We interpret these results to indicate that there was increased
autophagy after damage to mtDNA, another characteristic of the
aging cell.
Phagocytosis
Functionally, RPE cells are among the most active phagocytic
cells in the body [25]. To determine whether mtDNA damage and
autophagy affects phagocytosis, we measured the phagocytosis of
fluorescence labeled POS by ARPE-19 cells (Fig. 4). When cells
were exposed to fluorescence labeled POS for 3 hr, there was no
difference in the fluorescence intensity at different concentrations
of rotenone. The total fluorescence intensities from four
independent preparations in each group were calculated. Data
are presented as mean6SEM with statistical differences between
groups analyzed by standard two-tailed t-test using GraphPad
Prism software. A p value of less than 0.05 was considered
statistically significant. The damage to mtDNA and the increased
autophagy that we had caused in ARPE-19 cells had no impact on
phagocytic activity.
Lysosomal activity
Another major function of the RPE is to digest damaged
intracellular macromolecules arising from endosomes, phagosomes
and autophagy by the fusion with lysosomes. We determined
whether damage to mtDNA and increased autophagy affected
lysosomal activity. The most important lysosomal enzyme in RPE
cells is the aspartic protease cathepsin D [26]. Cathepsin D protein
levels were significantly decreased after mtDNA damage at 1.25–
2.5 mM rotenone, as demonstrated in the western blots in Fig. 5A.
Quantification of cathepsin D protein levels is shown in
Supplementary Figure S3. We used in vitro and in vivo assays
to measure cathepsin D activity. Cathepsin D enzymatic activity
from cell extracts was significantly decreased at 1.25–2.5 mM
rotenone (Fig. 5B). Five independent preparations in each group
were used for statistical analyses. Data are presented as mean6-
SEM with statistical differences between groups analyzed by
standard two-tailed t-test using GraphPad Prism software. A p
value of less than 0.05 was considered statistically significant. In
addition, we used an in vivo cathepsin D activity assay to observe
the impact of mtDNA damage, induced by rotenone treatment,
and increased autophagy on cathepsin D activity (Fig. 5C and D).
Intracellular cathepsin D activity was significantly decreased at
2.5 mM rotenone. The change in enzyme activity is consistent with
the change in protein levels (Fig. 5A).The results in Fig. 5, using
western blot and two different measures of cathepsin D activity,
independently confirmed that damage to mtDNA in ARPE-19
cells was associated with a small but significant decrease in
cathepsin D activity. Interestingly, using Western blots we found
that pre-pro-cathepsin D protein was increased at low concentra-
tions of rotenone treatment, which suggests that there was less
processing of pre-pro-cathepsin D to the mature form (Fig. 5A).
Figure 2. Increased autophagy markers in old mice. (A–B): Localization of Atg12 in young and old RPE/choroid in the mouse eye. (A) In the
eyes from young mice, there was no Atg12 labeling (red) in the RPE/choroid tissue. (B) In the RPE/choroids from old eyes, there was spotted labeling
(red, arrows) in the RPE. Scale bar=20 mm. (C–E): Comparison of protein levels of (C) Atg12-Atg5 conjugates and (D) LC3B in RPE/choroid of young
and old mice by immunoblot. Atg12-Atg5 conjugates and LC3B were all increased in RPE/choroid from old animals. (E) b-actin was used as a loading
control. (F): The differences in expression levels were determined by multiple scans of blots to ensure a maximium and minimum response range for
the measured areas and the integrated areas of the bands were calculated by using Image-J software. Data were expressed as normalized ratios
(Young =1). There were significant increases in aged retinas of Atg12-Atg5 (p,0.05, n=3) and LC3B (p,0.05, n=3), compared to young retinas.
Values are the mean6SEM. Appropriate background subtraction and normalization of the data to actin was done for each blot.
doi:10.1371/journal.pone.0004160.g002
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treatment alters the level of cathepsin D in the RPE needs to be
elucidated.
Exocytotic activity in stressed RPE
We reasoned that when RPE cells with damaged mtDNA,
increased autophagy and decreased lysosomal activity are
presented with POS, additional mechanisms must be needed to
handle the damaged intracellular macromolecules. We hypothe-
sized that compromised RPE will remove damaged intracellular
macromolecules without completely digesting them by increasing
exocytotic activity. Endosomes and the exosomes that they form
and release are capable of removing intracellular macromolecules.
We measured two markers for late endosomes and exosomes:
CD63 and LAMP2. As shown in Fig. 6A–D, exposure to 2.5 mM
rotenone for 24 hrs alone or exposure to POS for 12 hrs alone did
not change CD63 and LAMP2 gene expression at 36 hrs.
However, when the cells were treated with rotenone for 24 hrs,
and then exposed to POS for 12 hrs to increase phagocytosis,
expression of CD63 and LAMP2 were significantly increased. We
speculate that as a result of mtDNA damage and decreased
lysosomal activity, the cells increase their exocytotic activity as a
means to eliminate intracellular debris. The autophagy markers
that appear in drusen in the retina with age (Fig. 1) may be due, in
part, to an age-related cumulative increase of exocytotic activity.
Exosome markers in aged mouse RPE/choroids
We then asked whether we could find evidence for increased
exocytotic activity in the RPE/choroid with age. Six mouse eyes
were used for each group in immunohistochemistry experiments
and three mouse eyes were used for each group in Western blots.
Using immunohistochemistry and Western blots, we found
exosome marker proteins, CD63 and LAMP2 between RPE and
choroid in old, but not in young, mouse tissue (Fig. 7A–B).
Western blots of RPE/choroid from young and old eyes confirmed
the marked increase of CD63 and LAMP2 in old tissue (Fig. 7C–
Figure 3. Induction of autophagy in ARPE-19 cells. (A): Cell viability assay and ATP assay for ARPE-19 cells treated with rotenone.
Concentrations in the media of 0.08 to 2.5 mM did not cause a significant decrease of cell viability or ATP levels. (B): Rotenone at concentrations in the
media of 0.6 to 2.5 mM did not cause a significant decrease in CoQ levels. (C): Rotenone at concentrations in the media of 0.6 to 2.5 mM damaged
mtDNA, but not nDNA. (D): Comparison of protein levels of Atg12-Atg5 conjugates and LC3B in ARPE-19 cells by immunoblots. Atg12-Atg5
conjugates and LC3B were increased in ARPE-19 cells after 2.5 mM rotenone treatment. b-actin was used as a loading control.
doi:10.1371/journal.pone.0004160.g003
Figure 4. Phagocytotic activity of ARPE-19 cells. Rotenone at
concentrations in the media of 0.3–2.5 mM did not change phagocytic
activity when cells were exposed to photoreceptor outer segments for
3h r( p ,0.05, n=4).
doi:10.1371/journal.pone.0004160.g004
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associated with AMD [27]. Our laboratory previously demon-
strated that C3 increases with age and in the aged RPE/choroid
C3 deposits are large and discontinuous clumps along Bruch’s
membrane [28]. Interestingly, CD63 co-localized with C3,
suggesting an extracellular interaction between exosome proteins
and complement (Fig. 7 F–G). Thus, with age there is an
accumulation of exocytotic markers in the region of Bruch’s
membrane in mice.
Exosomes contain proteins found in human drusen
We found that exosome markers, CD63, CD81, LAMP2, were
present in drusen from AMD patients (Fig. 8A–C, three different
donors), but not in age-matched controls (Fig. 8D). Furthermore,
CD63 co-localized with proteins that are well known in human
drusen: amyloid b, aB-crystalline, C5b-9 and CFH (Fig. 8E–H).
CFH binding to exosomes
We reasoned that released exosomes might be a target of the
complement system. We therefore determined whether exosomes
from ARPE-19 cells bind C3 and/or CFH and if CFH binding
affected the amount of C3 associated with the exosomes. To verify
that we could collect exosomes released from RPE, we collected
exosomes from the cell media of ARPE-19 cells and demonstrated
the markers of exosomes. Using FACS, we found that exosomes
were, as expected, CD63, CD81 and LAMP2 positive (Fig. 9A:
blue, dark green and red lines respectively). Interestingly, these
exosomes were C3 positive (magenta line) but CFH negative (light
green line) (Fig. 9A). As shown in Fig. 9B, exosomes bound CFH
in a dose dependent manner. Binding of CFH did not alter the
amount of C3 (magenta line) associated with exosomes (Fig. 9C).
Thus, C3 coated exosomes released from the RPE, are possible
targets for CFH.
Cytokine and chemokine profiles
Our previous data, comparing gene expression profiles from
normal, young and old mice, show marked upregulation of genes
that are responsible for leukocyte extravasation in the aged RPE/
choroid. Prominent in the aged retina was the expression of
macrophage chemoattractant protein-1 (MCP-1), a chemokine
that attracts macrophages. We hypothesized that RPE cells with
decreased lysosomal activity and increased exocytotic activity will
release signals for recruitment of leukocytes, particularly macro-
phages, to aid in the digestion of extracellular deposits.
Figure 5. Lysosomal activity. (A) Comparison of protein levels of mature cathepsin D (33kD) and pre-pro-cathepsin D (48–52 kD) in ARPE-19 cells
by immunoblot. b-actin was used as a loading control. (B) Cathepsin D enzymatic activity from cell extracts were significantly decreased at 1.25–
2.5 mM concentrations of rotenone (p,0.05). (C) immunofluorescence of in vivo cathepsin D substrate showing uptake into the lysosomes of ARPE-19
cells (red: total substrate; green: cleaved substrate; blue: DAPI). (D) In vivo lysosomal activity assay showing lysosomal activity against a peptide
substrate for cathepsin D was significantly decreased at 2.5 mM rotenone (p,0.05). Scale bar=20 mm.
doi:10.1371/journal.pone.0004160.g005
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PLoS ONE | www.plosone.org 8 January 2009 | Volume 4 | Issue 1 | e4160Figure 6. Exosome markers in ARPE-19 cells. (A) Localization of CD63 in ARPE-19 cells without treatment. (B) 2.5 mM rotenone for 24 hrs or
exposure to POS 12 hrs alone did not change CD63 expression at 36 hrs. However, when the cells were treated with rotenone for 24 hrs to damage
their mtDNA and then fed POS for 12 hrs, CD63 was significantly increased (p,0.05). (C) Localization of LAMP2 in ARPE-19 cells without treatment. (D)
Exposure to 2.5 mM rotenone for 24 hrs alone or POS for 12 hrs alone did not change LAMP2 expression. However, when the cells were treated with
rotenone for 24 hrs to damage their mtDNA and then fed POS for 12 hrs, LAMP2 was significantly increased at 36 hrs (p,0.05).
doi:10.1371/journal.pone.0004160.g006
Figure 7. Exosome markers in RPE/choroid of mice. (A–B): Localization of CD63 in young and old RPE/choroid. (A) In the young RPE/choroid,
there was no CD63 labeling in the RPE layer or Bruch’s membrane. (B) In the old RPE/choroids, there was labeling in the RPE layer in old animals (small
arrow heads). CD63 deposition at Bruch’s membrane showed large and discontinuous clumps (arrows). (C–E): Comparison of protein levels of CD63
and LAMP2 in RPE/choroid of young and old mice by immunoblot. (C) CD63 and (D) LAMP2 were increased in the RPE/choroid from old animals. (E) b-
actin was used as a loading control. (F–G): Co-localization of CD63 (green) and C3 (red) in young and old RPE/choroids. (F) In the young RPE/choroid,
there was no co-localization of CD63 and C3 in the RPE layer or Bruch’s membrane. (G) In the old RPE/choroid, C3 co-localized with CD63 at Bruch’s
membrane (arrows). Figure F and G were overlay images with the brightfield image. Scale bar=20 mm.
doi:10.1371/journal.pone.0004160.g007
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and increased autophagy produce signals to recruit leukocytes, we
used the Human Cytokine Array for parallel determinations of 36
cytokines and chemokines (Fig. 10A). ARPE-19 cells treated with
rotenone (2.5 uM, 24 hr) exhibited increased release of MCP-1
and migration inhibitory factor (MIF). We confirmed these
changes quantitatively by ELISA (Fig. 10B–C). These results
predicted increased macrophages in eyes from old animals. In vivo
in old mice eyes, we found infiltration of F4/80 positive
macrophages into the RPE/choroid (Fig. 10D–E). These results
are consistent with the recruitment of leukocytes into the aged
RPE in rodents and the increased immunological activity with age
[28].
Discussion
The autophagy activity of living cells increases with age and is
due to an increased intracellular burden of damaged macromol-
ecules and organelles caused by reactive oxygen species during
aging [29]. Mitochondria are targets for oxidative stress from the
generation of free radicals which cause damage to the mtDNA.
Mitochondria with damaged mtDNA fuse with lysosomes for
degradation via a form of autophagy known as macroautophagy
[7]. Using an in vitro RPE model, we found that autophagy is
associated with mtDNA damage. Autophagy may exist in vivo in
the RPE of old eyes. We have demonstrated that there are markers
for autophagy in the RPE/choroid of old mice. We have also
found that autophagy markers are present in drusen in the human
retina. We provide the first evidence for increased autophagy
activity in the aging RPE and the presence of autophagy markers
in drusen of the eyes of old human donors. An in-depth study of
autophagy in the aging RPE and how markers of autophagy
become a component of drusen is warranted.
A major function of the RPE is the phagocytosis and digestion
of photoreceptor outer segments. Our results indicate that RPE
cells with mtDNA damage are competent in the internalization
steps of phagocytosis. Digestion of POS requires cathepsin D
proteolytic activity in the lysosome [26]. We found a significant
decrease in cathepsin D activity in cultured ARPE-19 cells.
However, increased cathepsin D activity has been reported for the
human RPE with age [30].Thus, this result of in vitro modeling of
mtDNA damage in ARPE-19, which is a human, transformed cell
line, are not consistent with the in vivo findings. Perhaps the RPE
in an old eye in vivo has the ability to upregulate cathepsin D
activity as a response to age-related, intracellular accumulation of
damaged molecules and organelles. Whether the aged RPE can
process the age-related mtDNA damage, increase autophagy
activity and maintain the daily function of phagocytosis of POS
remains to be determined.
Intracellular overload of damaged macromolecules leads to
increased exocytotic activity. Exocytotic activity includes the
formation of endosomes, multi-vesicular bodies and the release
of exosomes from the cell. Released exosomes carry undigested or
partially digested intracellular proteins out of the cell. Although it
is not possible to collect exosomes from a tissue in vivo, our model
of autophagy in ARPE-19 cells demonstrates that exosome
markers are upregulated when the cells are stressed by oxidative
damage to mtDNA and are presented with POS to digest. In vivo,
the RPE in the aged eye may be releasing increased numbers of
exosomes containing intracellular proteins. We provide the first
evidence for an apparent increased exocytotic activity in the aging
RPE. Interestingly, there are increased exosome markers sur-
rounding Bruch’s membrane in the old mouse eye, implying that
released exosomes or their contents are being trapped locally in
the tissue. Consistent with the old mouse eye, there are exosome
markers in drusen from eyes of AMD patients. We postulate that
age-related, increased release of exosomes externalizes intracellu-
lar proteins.
Based on published studies of exosome proteomics from
different cell types, we found marked similarity of the intracellular
proteins reported in the literature that are found in drusen [3,31]
and the intracellular proteins that are found in exosomes [32]
(Table 2). Furthermore, recent proteomic analyses of Bruch’s
membranes from AMD patients have detected over 80 proteins
that are reported to be excreted in exosomes, including the
exosome markers: CD63, CD81 and CD9 (personal communica-
tion, John W Crabb). Therefore, the exocytosis process may
contribute intracellular proteins which become building material
for the formation of drusen on Bruch’s membrane.. Certainly, an
in-depth study of the exocytotic activity in the RPE of AMD
patients is likely to be fruitful.
We hypothesize that, in the aged RPE in vivo, there is age-
related, increased exocytotic activity lead to the release of
intracellular proteins via exosomes which contribute to the
formation of drusen. Blood proteins and extracellular proteins
are normally present in the RPE/choroid extracellular environ-
ment. We suggest that in the aging eye the formation of drusen is
Figure 8. Immunolocalization of exosome markers in the RPE/
choroid complex. (A): CD63 (red); AMD eye from a 74-year-old male.
Anti-CD63 antibody labels large amorphous areas (CD63: arrows) in
drusen. (B):CD81 (red); AMD eye from a 96-year-old male (CD81, arrows).
(C): LAMP2 (red). AMD eye from a 93-year-old (LAMP2, arrow). (D): CD63
(red); Non-AMD eye from a 75-year-old male as an age-matched control.
No CD63 labeling was seen in the drusen from any age-matched control
(n=10). (E–H): CD63 (green) co-localization with proteins that are
known to be in drusen. (E) amyloid b (red) showed no co-localization
with CD63 (arrow). (F) a B crystalline (red) showed co-localization with
CD63 (arrowhead). (G) C5b-9 (red) showed no co-localization with CD63
(arrow). (H) CFH (red) showed co-localization with CD63 (arrowhead).
Dr, drusen. Blue: DAPI.
doi:10.1371/journal.pone.0004160.g008
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extracellular via exosomes.
Although we have not studied any one process in detail, our
findings link aspects of aging, oxidative stress, mtDNA damage,
autophagy, lysosomal activity, exocytotic activity as functional
processes of RPE that have changed in the aged eye. Clearly, age-
related changes in autophagy, exocytosis and other functions of the
RPE need to be studied further. These altered cell biological
Figure 9. Analyses of exosomes by FACS. (A) Exoxomes are CD63, LAMP2, CD81 and C3 positive, but CFH negative. Isotype control: Black; CFH:
light green; CD63: blue; LAMP2: red; CD81: dark green; C3: magenta. (B) Added CFH bound to exosomes in a dose-dependent manner. (C) Added CFH
did not alter the amount of C3 on exosomes. For B and C: CFH 0.5 mg/mL: black; CFH 0.05 mg/mL: blue; CFH 0.005 mg/mL: purple; CFH 0.0005 mg/
mL: green; CFH 0 mg/mL: red.
doi:10.1371/journal.pone.0004160.g009
Figure 10. Cytokines secreted from RPE cells and macrophage infiltration into old mouse RPE. (A) Human Cytokine Array of media from
ARPE-19 cells. MCP-1, MIF, CXCL1, IL-8 and PAI-1 were detectable in both the control group and after rotenone treatmen t and appear to increase
under conditions of increased mtDNA damage. (B) MCP-1 ELISA. MCP-1 protein from cell media was significantly increased at 1.25–2.5 mM
concentrations of rotenone (p,0.05). (C) MIF ELISA. MIF protein from cell media was significantly increased at 0.6–2.5 mM concentrations of rotenone
(p,0.05). (D) Absence of F4/80 labeled macrophages in young RPE/choroid tissue (overlaid with a brightfield image; (E) F4/80 labeled macrophages
infiltrated into old RPE/choroid tissue (red). Arrows indicate that most of the macrophages are on the choroid side of Bruch’s membrane.
doi:10.1371/journal.pone.0004160.g010
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mutations that are found in AMD patients and may be associated
with the pathogenesis of AMD in the elderly.
Intracellular overload of damaged macromolecules may lead to
inflammatory cells entering the aged RPE/choroid. For example,
macrophages may invade the tissue in response to increased
expression of MCP-I and MIF, which we demonstrated occurs
after mtDNA damage. In previous work, we demonstrated that the
aged RPE/choroid becomes immunologically active [28]. Human
genetics investigations have focused on the CFH gene, a mutation
of which increases risk of AMD in both homozygotes and
heterozygotes [33,34]. Our observation that exosomes released by
ARPE-19 cells are coated with C3 suggests that exosomes interact
with the complement pathways. C3 coated exosomes from the
RPE which, as we have shown, bind CFH may be stabilized and
removed by the circulation. A mutation in CFH may make C3
coated exosomes, released from RPE, targets for the immunolog-
ical activity of the invading leukocytes in the old RPE/choroid. In
the presence of invading leukocytes in the aged tissue, CFH
dysfunction in the complement pathway may cause destabilization
of the exosome membrane release of intracellular proteins into the
external environment and, possibly incorporation of intracellular
proteins into drusen. These events, to the extent that they occur in
the human macula, may lead to the pathogenesis of AMD.
Supporting Information
Figure S1 Agarose gel electrophoresis of mtDNA PCR products.
All were single bands of the appropriate size. Lane 1: {lower case
lambda DNA-HindIII digest standards; Lane 2: empty; Lane 3:
16.2 Kb mtDNA (arrow), control; Lane 4: 16.2 Kb mtDNA (arrow),
2.5 mMr o t e no n et r e a tm e n t ;L a n e5 :7 . 5K bm tD N A( ar r ow ) ,c on t r o l ;
Lane 6: 7.5 Kb mtDNA (arrow), 2.5 mM rotenone treatment.
Found at: doi:10.1371/journal.pone.0004160.s001 (0.10 MB TIF)
Figure S2 Expression of Atg5 and LC3B in ARPE-19 cells. The
differences in expression levels were determined by multiple scans
of blots to ensure a maximium and minimum response range for
the measured areas and the integrated areas of the bands were
calculated by using Image-J software. Data are expressed as
normalized ratios to actin. Values are the mean6SEM. Appro-
priate background subtraction and normalization of the data to
actin was done for each blot. There were significant increases in
2.5 mM rotenone treatment of Atg5 (p,0.05, n=3) and LC3B
(p,0.05, n=3), compared to normal controls.
Found at: doi:10.1371/journal.pone.0004160.s002 (0.13 MB TIF)
Figure S3 Expression of cathepsin D in ARPE-19 cells. The
differences in expression levels of cathepsin D were determined by
scanning gels and determining the integrated areas of the bands
using Image-J software. Data are expressed as normalized ratios to
actin. Values are the mean6SEM. Appropriate background
subtraction and normalization of the data to actin was done for
each blot. There were significant decreases in 1.25 and 2.5 mM
rotenone treatment of cathepsin D (p,0.05, n=5), compared to
normal controls.
Found at: doi:10.1371/journal.pone.0004160.s003 (2.93 MB TIF)
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